In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

WGAL NEWS EIGHT. COVID, FLU AND RSV WILL ALL SOON BE CIRCULATING, UPDATED COVID VACCINES ARE AVAILABLE ALONG WITH FLU AND RSV. VACCINES SHOULD EVERYONE GET THE RSV VACCINE? I’M JOINED NOW BY ...

Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Vaccines for the fall and winter 2024–2025 season are now available. Generally, experts recommend COVID-19 and flu vaccines for most people and RSV vaccines ... February. In order to ensure ...

The new respiratory syncytial virus (RSV) vaccines recommended for individuals aged 60 years and older may provide individual and societal cost-savings benefits, a study suggests. 1 "We view this ...

GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older. The British pharma giant ...

Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season. “Our top ...